TFF Pharmaceuticals (TFFP)
(Delayed Data from NSDQ)
$1.87 USD
-0.02 (-1.06%)
Updated Oct 3, 2024 03:59 PM ET
After-Market: $1.87 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for TFF Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -21.24 | -31.77 | -31.04 | -18.57 | -11.87 |
Depreciation/Amortization & Depletion | 0.50 | 0.39 | 0.11 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | 1.53 | -0.21 | -2.18 | -0.26 | 0.06 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.18 | 4.25 | 3.55 | 2.21 | 0.59 |
Net Cash From Operating Activities | -16.04 | -27.34 | -29.56 | -16.62 | -11.22 |
Property & Equipment | -0.09 | -1.55 | -0.87 | -1.10 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.09 | -1.55 | -0.87 | -1.10 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.12 | 11.75 | 28.88 | 24.99 | 29.05 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 5.01 | 11.75 | 28.88 | 24.99 | 29.05 |
Effect of Exchange Rate Changes | -0.01 | -0.04 | 0.03 | -0.07 | 0.00 |
Net Change In Cash & Equivalents | -11.13 | -17.18 | -1.51 | 7.21 | 17.83 |
Cash at Beginning of Period | 16.61 | 33.79 | 35.30 | 28.09 | 10.26 |
Cash at End of Period | 5.48 | 16.61 | 33.79 | 35.30 | 28.09 |
Diluted Net EPS | -11.85 | -26.50 | -31.25 | -22.75 | -132.75 |
Fiscal Year End for TFF Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -10.21 | -5.74 | -21.24 | -16.48 | -12.07 |
Depreciation/Amortization & Depletion | 0.28 | 0.14 | 0.50 | 0.37 | 0.25 |
Net Change from Assets/Liabilities | 1.77 | 1.85 | 1.53 | 1.16 | 0.69 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.77 | 0.60 | 3.18 | 3.12 | 2.31 |
Net Cash From Operating Activities | -6.40 | -3.14 | -16.04 | -11.82 | -8.82 |
Property & Equipment | 0.00 | 0.00 | -0.09 | -0.05 | -0.04 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | -0.09 | -0.05 | -0.04 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.41 | 0.92 | 5.12 | 5.09 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.08 | -0.02 | -0.11 | -0.08 | -0.08 |
Net Cash from Financing Activities | 5.33 | 0.90 | 5.01 | 5.01 | -0.08 |
Effect of Exchange Rate Changes | -0.02 | -0.02 | -0.01 | -0.03 | -0.01 |
Net Change In Cash & Equivalents | -1.09 | -2.27 | -11.13 | -6.89 | -8.95 |
Cash at Beginning of Period | 5.48 | 5.48 | 16.61 | 16.61 | 16.61 |
Cash at End of Period | 4.39 | 3.21 | 5.48 | 9.73 | 7.66 |
Diluted Net EPS | -1.22 | -2.40 | -1.35 | -2.25 | -3.50 |